Tag: CAP V Mauritius Ltd

Piramal Pharma completes 20% strategic growth investment by Carlyle

Piramal Pharma Limited (PPL), a subsidiary of Piramal Enterprises Limited (PEL), announced that it has received INR 3523.40 Crores on closure of the transaction for 20% equity investment from CA Alchemy Investments (formerly known as CA Clover Intermediate II Investments), an affiliated entity of CAP V Mauritius Limited, an investment fund managed and advised by…

Carlyle to acquire about 25% stake in Airtel’s Data Centre business

Bharti Airtel, India’s largest integrated telecommunications operator, and Comfort Investments II, an affiliated entity of CAP V Mauritius Limited, an investment fund managed and advised by affiliated entities of The Carlyle Group, announced an agreement under which Comfort Investments II will invest $235 million in Nxtra Data Limited, a wholly owned subsidiary of Airtel engaged…